UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Stock Position in USANA Health Sciences, Inc. (NYSE:USNA)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its position in USANA Health Sciences, Inc. (NYSE:USNA) by 42.0% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 9,423 shares of the company’s stock after selling 6,810 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in USANA Health Sciences were worth $357,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in USNA. American Century Companies Inc. grew its stake in USANA Health Sciences by 12.3% in the 2nd quarter. American Century Companies Inc. now owns 159,782 shares of the company’s stock valued at $7,229,000 after buying an additional 17,460 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of USANA Health Sciences by 13.5% in the third quarter. Assenagon Asset Management S.A. now owns 124,008 shares of the company’s stock worth $4,702,000 after acquiring an additional 14,756 shares during the period. Allspring Global Investments Holdings LLC grew its position in shares of USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock valued at $1,472,000 after purchasing an additional 38,547 shares in the last quarter. Pzena Investment Management LLC raised its stake in shares of USANA Health Sciences by 24.4% during the 2nd quarter. Pzena Investment Management LLC now owns 976,633 shares of the company’s stock valued at $44,183,000 after purchasing an additional 191,289 shares during the period. Finally, Deerfield Management Company L.P. Series C raised its stake in shares of USANA Health Sciences by 297.0% during the 2nd quarter. Deerfield Management Company L.P. Series C now owns 29,742 shares of the company’s stock valued at $1,346,000 after purchasing an additional 22,251 shares during the period. Hedge funds and other institutional investors own 54.25% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on USNA. DA Davidson raised USANA Health Sciences to a “hold” rating in a report on Friday. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Thursday.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

USANA Health Sciences Stock Down 3.8 %

USANA Health Sciences stock opened at $33.38 on Friday. The business has a 50-day simple moving average of $37.91 and a 200 day simple moving average of $40.37. USANA Health Sciences, Inc. has a 52 week low of $33.28 and a 52 week high of $54.81. The stock has a market cap of $636.22 million, a price-to-earnings ratio of 11.80, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.07. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same period in the previous year, the business posted $0.59 earnings per share. On average, research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.